Bloomage BioTechnology Corporation Limited (SHA:688363)
China · Delayed Price · Currency is CNY 35.18
+0.21 (0.60%)
Sep 4, 2026, 3:00 PM CST
SHA:688363 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 857.78 | 994.98 | 719.27 | 1,169 | 1,606 | 1,807 |
Trading Asset Securities | 289.83 | 33.29 | 30.02 | 140.04 | 530.72 | 846.89 |
Cash & Short-Term Investments | 1,148 | 1,028 | 749.29 | 1,309 | 2,137 | 2,654 |
Cash Growth | 47.77% | 37.23% | -42.75% | -38.75% | -19.47% | 25.58% |
Accounts Receivable | 562.15 | 566.78 | 547.38 | 450.19 | 457.87 | 402.22 |
Other Receivables | 40.48 | 42.26 | 45.27 | 39.42 | 51.91 | 28.9 |
Receivables | 602.63 | 609.05 | 592.65 | 489.61 | 509.78 | 431.12 |
Inventory | 881.12 | 980.62 | 1,248 | 1,135 | 1,162 | 709.13 |
Other Current Assets | 216.96 | 167.05 | 150.96 | 189.99 | 214.93 | 190.37 |
Total Current Assets | 2,848 | 2,785 | 2,741 | 3,123 | 4,023 | 3,984 |
Property, Plant & Equipment | 4,032 | 4,090 | 4,203 | 3,657 | 2,913 | 2,305 |
Long-Term Investments | 737.13 | 570.13 | 585.02 | 502.99 | 592.63 | 400.32 |
Goodwill | 171.02 | 177.62 | 174.09 | 251.28 | 247.22 | 67.15 |
Other Intangible Assets | 518.18 | 517.62 | 490.63 | 496.97 | 475.06 | 467.26 |
Long-Term Deferred Tax Assets | 349.39 | 335.56 | 355.56 | 336.98 | 302.59 | 246.11 |
Long-Term Deferred Charges | 141.69 | 155.12 | 100.34 | 98.14 | 116.43 | 31.85 |
Other Long-Term Assets | 83.28 | 61.93 | 7.51 | 3.63 | 11.5 | 1.44 |
Total Assets | 8,881 | 8,693 | 8,657 | 8,470 | 8,682 | 7,504 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 641.49 | 140.14 | 195.41 | 186.78 | 247.75 | 243.55 |
Accrued Expenses | 119.54 | 368.78 | 587.09 | 479.49 | 672.75 | 704.09 |
Short-Term Debt | 216.33 | 92.89 | 49.92 | - | 139.2 | - |
Current Portion of Long-Term Debt | 77.59 | 64.93 | 28.89 | 106.08 | 36.54 | 36.46 |
Current Portion of Leases | - | 49.39 | 62.79 | 47.05 | 53.67 | 49.61 |
Current Income Taxes Payable | 59.58 | 8.72 | 13.85 | 55.68 | 76.43 | 135.52 |
Current Unearned Revenue | 86.93 | 57.77 | 63.48 | 55.58 | 67.74 | 50.83 |
Other Current Liabilities | 126.58 | 407.39 | 339.6 | 290.13 | 349.97 | 180.46 |
Total Current Liabilities | 1,328 | 1,190 | 1,341 | 1,221 | 1,644 | 1,401 |
Long-Term Debt | 135.86 | 94.66 | 65.12 | 2.32 | 107.97 | 144.18 |
Long-Term Leases | 52.42 | 39.51 | 152.97 | 52.66 | 52.42 | 69.77 |
Long-Term Unearned Revenue | 237.31 | 248.94 | 253.24 | 205.73 | 188.68 | 182.71 |
Long-Term Deferred Tax Liabilities | 3.01 | 4.24 | 4.57 | 5.09 | 5.66 | 4.12 |
Total Liabilities | 1,757 | 1,577 | 1,817 | 1,487 | 1,999 | 1,801 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 481.68 | 481.68 | 481.68 | 481.68 | 481.09 | 480 |
Additional Paid-In Capital | 3,850 | 3,850 | 3,853 | 3,841 | 3,753 | 3,569 |
Retained Earnings | 3,002 | 2,940 | 2,700 | 2,708 | 2,409 | 1,674 |
Treasury Stock | -219.95 | -219.95 | -219.95 | -105.88 | - | - |
Comprehensive Income & Other | -22.63 | 34.65 | -4.32 | 19.57 | -9.1 | -23.91 |
Total Common Equity | 7,090 | 7,086 | 6,810 | 6,944 | 6,634 | 5,699 |
Minority Interest | 34.07 | 29.49 | 29.63 | 39.33 | 49.21 | 3.45 |
Shareholders' Equity | 7,124 | 7,115 | 6,840 | 6,983 | 6,683 | 5,702 |
Total Liabilities & Equity | 8,881 | 8,693 | 8,657 | 8,470 | 8,682 | 7,504 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 482.21 | 341.38 | 359.69 | 208.1 | 389.79 | 300.01 |
Net Cash (Debt) | 665.4 | 686.9 | 389.6 | 1,101 | 1,747 | 2,354 |
Net Cash Growth | 22.57% | 76.31% | -64.60% | -37.00% | -25.77% | 12.67% |
Net Cash Per Share | 1.39 | 1.43 | 0.80 | 2.28 | 3.62 | 4.87 |
Filing Date Shares Outstanding | 493.12 | 478.36 | 478.36 | 480.26 | 481.09 | 480 |
Total Common Shares Outstanding | 493.12 | 478.36 | 478.36 | 480.26 | 481.09 | 480 |
Working Capital | 1,520 | 1,595 | 1,400 | 1,902 | 2,379 | 2,584 |
Book Value Per Share | 14.38 | 14.81 | 14.24 | 14.46 | 13.79 | 11.87 |
Tangible Book Value | 6,401 | 6,390 | 6,145 | 6,196 | 5,911 | 5,165 |
Tangible Book Value Per Share | 12.98 | 13.36 | 12.85 | 12.90 | 12.29 | 10.76 |
Buildings | - | 2,477 | 2,496 | 1,756 | 1,385 | 1,269 |
Machinery | - | 2,260 | 1,794 | 1,410 | 1,148 | 812.35 |
Construction In Progress | - | 438.52 | 640.98 | 1,109 | 830.45 | 516.72 |